Properties of the myc and myb Gene Products

  • Karin Moelling

Abstract

The myc and myb oncogenes were originally discovered as the transforming genes in certain avian retrovirus strains and have recently also been implicated in the genesis of human hematopoietic neoplasms. Their gene products were the first transforming proteins found to be localized in the nucleus and are therefore possibly involved in the regulation of gene expression. In this article some of the properties of viral and cellular myc and myb proteins will be reviewed and their possible roles during normal and neoplastic processes discussed.

Keywords

Lymphoma Leukemia Fractionation Proline Interferon 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams JM, Harris AW, Pinkert CA, Corcoran CM, Alexander WS, Cory S, Palmiter RD, Brinster RL (1985) The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318: 533–538PubMedCrossRefGoogle Scholar
  2. Beimling P, Benter T, Sander T, Moelling K (1985) Isolation and characterization of the human cellular myc gene product. Biochemistry 24: 6349–6355PubMedCrossRefGoogle Scholar
  3. Blanchard J-M, Piechaczyk M, Dani C, Chambard J-C, Franchi A, Pouyssegur J, Jeanteur P (1985) c-myc gene is transcribed at high rate Go-arrested fibroblasts and is post-transcriptionally regulated in response to growth factors. Nature 317:443–445PubMedCrossRefGoogle Scholar
  4. Bunte T, Greiser-Wilke I, Donner P, Moelling K (1982) Association of gag-myc proteins from avian myelocytomatosis virus wild-type and mutants with chromatin. EMBO J 1: 919–927PubMedGoogle Scholar
  5. Butnick NZ, Miyamoto C, Chizzonite R, Cullen BR, Ju G, Skalka AM (1985) Regulation of the human c-myc gene: 5’ noncoding sequences do not affect translation. Mol Cell Biol 5: 3009–3016PubMedGoogle Scholar
  6. Campisi J, Gray HE, Pardee AB, Dean M, Sonenshein GE (1984) Cell-cycle control of c-myc but not c-ras expression is lost following chemical transformation. Cell 36: 241–247PubMedCrossRefGoogle Scholar
  7. Cole MD (1985) Regulation and activation of c-myc. Nature 318: 510–511PubMedCrossRefGoogle Scholar
  8. Dani C, Blanchard JM, Piechaczyk M, El Sabouty S, Marty L, Jeanteur P (1984) Extreme instability of myc mRNA in normal and transformed human cells. Proc Natl Acad Sci USA 81: 7046–7050PubMedCrossRefGoogle Scholar
  9. Dani C, Mechti N, Piechaczyk M, Lebleu B, Jeanteur P, Blanchard JM (1985) Increased rate of degradation of c-myc RNA in interferon-treated Daudi cells. Proc Natl Acad Sci USA 82: 4896–4899PubMedCrossRefGoogle Scholar
  10. Darveau A, Pelletier J, Sonenberg N (1985) Differential efficiencies of in vitro translation of mouse c-myc transcripts differing in the 5’ untranslated region. Proc Natl Acad Sci USA 82:2315–2319PubMedCrossRefGoogle Scholar
  11. Donner P, Greiser-Wilke I, Moelling K (1982) Nuclear localization and DNA binding of the transforming gene product of avian myelocytomosis virus. Nature 296: 262–266PubMedCrossRefGoogle Scholar
  12. Donner P, Bunte T, Greiser-Wilke I, Moelling K (1983) Decreased DNA-binding ability of purified transformation-specific proteins from deletion mutants of the acute avian leukemia virus MC29. Proc Natl Acad Sci USA 80: 2861–2865PubMedCrossRefGoogle Scholar
  13. Dyson PJ, Littlewood TD, Forster A, Rabbitts TH (1985) Chromatin structure of transcriptionally active and inactive human c-myc alleles. EMBO J 4: 2885–2891PubMedGoogle Scholar
  14. Evan GI, Hancock DC (1985) Studies on the interaction of the human c-myc protein with cell nuclei: p62 my as a member of a discrete subset of nuclear proteins. Cell 43: 253–261PubMedCrossRefGoogle Scholar
  15. Evan GI, Lewis GK, Bishop JM (1984) Isolation of monoclonal antibodies specific for products of avian oncogene myb. Mol Cell Biol 4: 2843–2850PubMedGoogle Scholar
  16. Hann SR, Eisenman RN (1984) Proteins encoded by the human c-myc oncogene differential expression in neoplastic cells. Mol Cell Biol 4: 2486–2497PubMedGoogle Scholar
  17. Hann SR, Thompson CB, Eisenman RN (1985) c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature 314:366–369PubMedCrossRefGoogle Scholar
  18. Kalderon D, Roberts BL, Richardson WD, Smith A (1984) A short amino acid sequence able to specify nuclear location. Cell 39: 499–509PubMedCrossRefGoogle Scholar
  19. Kelly K, Cochran BH, Stiles CD, Leder P (1984) Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell 35: 603–610CrossRefGoogle Scholar
  20. Kingston RE, Baldwin AS, Sharp PA (1984) Regulation of heat shock protein 70 gene expression by c-myc. Nature 312: 280–282PubMedCrossRefGoogle Scholar
  21. Klempnauer KH, Sippel A (1986) Subnuclear localization of proteins encoded by the oncogene v-myb and its cellular homolog c-myb. Mol Cell Biol 6: 62–69PubMedGoogle Scholar
  22. Klempnauer KH, Symonds G, Evan GI, Bishop JM (1984) Subcellular localization of proteins encoded by oncogenes of avian myeloblastosis virus and avian leukemia virus E26 and by the chicken c-myb gene. Cell 37: 537–547PubMedCrossRefGoogle Scholar
  23. Moelling K (1985) Fusion proteins in retroviral transformation. In: Weinhouse S, Klein G (eds) Advances in cancer research, vol 43. Academic Press, London New York, pp 205–239Google Scholar
  24. Moelling K, Pfaff E, Beug H, Beimling P, Bunte T, Schaller HE, Graf T (1985) DNA-binding activity is associated with purified myb proteins from AMY and E26 viruses and is temperature-sensitive for E26 is mutants. Cell 40: 983–900PubMedCrossRefGoogle Scholar
  25. Moelling K, Lorenz U, Beimling P, Heimann B, Thomas G, Bading H, Sander T (1986) Biochemical properties of oncogene-coded proteins. In: Gallwitz D, Tanner W (eds) Cell cycle and oncogenes, 37th Mosbach Colloquium. Springer, Berlin Heidelberg New York, (in press)Google Scholar
  26. Nau MM, Brooks BJ, Battey J, Sansville E, Gazdar AF, Kirsch IR, McBride OW, Bertness V, Hollis GF, Minna JD (1985) L-myc, a myc-related gene amplified and expressed in human small cell lung cancer. Nature 318: 69–73PubMedCrossRefGoogle Scholar
  27. Pelicci P-G, Lanfrancone L, Braithwaite MD, Wolman SR, Dalla-Favera R (1984) Amplification of the c-myb oncogene in a case of human acute myelogenous leukemia. Science 224: 1117–1121PubMedCrossRefGoogle Scholar
  28. Persson H, Leder P (1984) Nuclear localization and DNA binding properties of protein expressed by human c-myc oncogene. Science 225: 718–721PubMedCrossRefGoogle Scholar
  29. Persson H, Gray H, Godeau F, Braunhut S, Bellvé AR (1986) Multiple growth-associated nuclear proteins immunoprecipitated by antisera raised against human c-myc peptide antigens. Mol Cell Biol 6: 942–949PubMedGoogle Scholar
  30. Rabbitts TH (1985) The c-myc proto-oncogene: involvement in chromosomal abnormalities. Trends Gen Dec 327–331Google Scholar
  31. Rapp UR, Cleveland JL, Brightman K, Scott A, Ihle JN (1985) Abrogation of IL-3 and IL-2 dependence by recombinant murine retroviruses expressing v-myc oncogenes. Nature 317: 434–438PubMedCrossRefGoogle Scholar
  32. Siebenlist U, Henninghausen L, Battey J, Leder P (1984) Chromatin structure and protein binding in the putative regulatory region of the c-myc gene in Burkitt lymphoma. Cell 37: 381–391PubMedCrossRefGoogle Scholar
  33. Thompson CB, Challoner PB, Neiman PE, Groudine M (1986) Expression of the c-myb protooncogene during cellular proliferation. Nature 319: 374–380PubMedCrossRefGoogle Scholar
  34. Watt RA, Shatzman AR, Rosenberg M (1985) Expression and characterization of the human c-myc DNA-binding protein. Mol Cell Biol 5: 448–456PubMedGoogle Scholar
  35. Winqvist R, Saksela K, Alitalo K (1984) The myc proteins are not associated with chromatin in mitotic cells. EMBO J 3: 2947–2950PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • Karin Moelling

There are no affiliations available

Personalised recommendations